Nathalie Rioux-Leclerc

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

Mathieu Lemaire, Véronique Frémeaux‐Bacchi, Franz Schaefer et al. · Nature Genetics · 2013 · 478 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status

Yosra Messai, Sophie Gad, Muhammad Zaeem Noman et al. · European Urology · 2015 · 176 citations

Medicine, Cancer Biology, Oncology +14

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

Florian Cabillic, Olivier Toutirais, Vincent Lavoué et al. · Cancer Immunology Immunotherapy · 2010 · 68 citations · Full text

Life Sciences, Immunology, Oncology +16

Prognostic and predictive values of oncogenic <i>BRAF, NRAS, c‐KIT</i> and <i>MITF</i> in cutaneous and mucous melanoma

Marc Pracht, Ariane Mogha, Alexandra Lespagnol et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 39 citations

Medicine, Dermatology, Oncology +16

Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders

Vincent Javaugue, Céline Debiais-Delpech, M. Nouvier et al. · Kidney International · 2019 · 29 citations · Full text

Medicine, Nephrology, Pathology +15